Analystreport

Stoke Therapeutics (NASDAQ: STOK) had its "buy" rating re-affirmed by analysts at Cowen Inc.

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report